Free Trial

Denali Therapeutics (DNLI) Insider Trading & Ownership

Denali Therapeutics logo
$24.16 -0.26 (-1.06%)
(As of 10:31 AM ET)

Denali Therapeutics (NASDAQ:DNLI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.90%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$6.31 M
Get DNLI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Denali Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

DNLI Insider Buying and Selling by Quarter

Denali Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/7/2024Alexander O SchuthInsiderSell15,558$29.91$465,339.78  
11/7/2024Vicki L SatoDirectorSell1,020$30.00$30,600.00  
10/18/2024Ryan J WattsCEOSell40,000$27.69$1,107,600.00  
9/30/2024Steve E KrognesDirectorSell30,000$29.03$870,900.00  
7/1/2024Steve E KrognesDirectorSell30,000$22.12$663,600.00  
6/13/2024Steve E KrognesDirectorSell688$21.79$14,991.52  
6/6/2024Jennifer E CookDirectorSell1,458$21.73$31,682.34  
4/15/2024Vicki L SatoDirectorSell1,666$18.29$30,471.14  
4/1/2024Steve E KrognesDirectorSell92,500$20.50$1,896,250.00  
2/15/2024Vicki L SatoDirectorSell1,666$18.37$30,604.42  
2/13/2024Carole HoInsiderSell2,784$17.29$48,135.36  
2/13/2024Ryan J WattsCEOSell9,589$17.29$165,793.81  
2/13/2024Steve E KrognesDirectorSell2,750$17.29$47,547.50  
1/16/2024Vicki L SatoDirectorSell1,666$18.42$30,687.72  
1/10/2024Carole HoInsiderSell4,668$19.02$88,785.36  
1/9/2024Ryan J WattsCEOSell7,818$19.78$154,640.04  
1/5/2024Carole HoInsiderSell9,972$19.43$193,755.96  
1/5/2024Ryan J WattsCEOSell17,483$19.43$339,694.69  
1/5/2024Steve E KrognesDirectorSell3,208$19.43$62,331.44  
12/15/2023Vicki L SatoDirectorSell1,666$23.39$38,967.74  
(Data available from 1/1/2013 forward)

DNLI Insider Trading Activity - Frequently Asked Questions

The list of insiders at Denali Therapeutics includes Alexander O Schuth, Carole Ho, Jennifer E Cook, Marc Tessier-Lavigne, Ryan J Watts, Steve E Krognes, and Vicki L Sato. Learn more on insiders at DNLI.

7.90% of Denali Therapeutics stock is owned by insiders. Learn more on DNLI's insider holdings.

The following insiders have sold DNLI shares in the last 24 months: Alexander O Schuth ($1,470,393.86), Carole Ho ($950,856.53), Jennifer E Cook ($31,682.34), Marc Tessier-Lavigne ($609,600.00), Ryan J Watts ($3,829,413.31), Steve E Krognes ($3,810,529.72), and Vicki L Sato ($406,482.92).

Insiders have sold a total of 445,563 Denali Therapeutics shares in the last 24 months for a total of $11,108,958.68 sold.

Denali Therapeutics Key Executives

  • Dr. Ryan J. Watts Ph.D. (Age 48)
    Co-Founder, President, CEO & Director
    Compensation: $1.15M
  • Dr. Alexander O. Schuth M.D.Dr. Alexander O. Schuth M.D. (Age 51)
    Co-Founder, CFO, COO & Secretary
    Compensation: $802.29k
    1 recent trades
  • Dr. Marc Tessier-Lavigne Ph.D. (Age 64)
    Co-Founder & Independent Director
    Compensation: $57.5k
  • Dr. Carole Ho M.D. (Age 51)
    Chief Medical Officer & Head of Development
    Compensation: $802.29k
  • Mr. Tyler M. Nielsen (Age 46)
    Senior Vice President of Corporate Finance
  • Dr. Dana Andersen
    Chief Technical and Manufacturing Officer
  • Mr. Joe Lewcock Ph.D.
    Chief Scientific Officer
  • Dr. Laura Hansen
    Vice President of Investor Relations
  • Mr. Chris Walsh
    General Counsel
  • Mr. Mark Rowen
    Vice President of Corporate Development


This page (NASDAQ:DNLI) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners